TY - JOUR
T1 - MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
AU - Mohammed Ismail, Wazim
AU - Mazzone, Amelia
AU - Ghiraldini, Flavia G.
AU - Kaur, Jagneet
AU - Bains, Manvir
AU - Munankarmy, Amik
AU - Bagwell, Monique S.
AU - Safgren, Stephanie L.
AU - Moore-Weiss, John
AU - Buciuc, Marina
AU - Shimp, Lynzie
AU - Leach, Kelsey A.
AU - Duarte, Luis F.
AU - Nagi, Chandandeep S.
AU - Carcamo, Saul
AU - Chung, Chi Yeh
AU - Hasson, Dan
AU - Dadgar, Neda
AU - Zhong, Jian
AU - Lee, Jeong Heon
AU - Couch, Fergus J.
AU - Revzin, Alexander
AU - Ordog, Tamas
AU - Bernstein, Emily
AU - Gaspar-Maia, Alexandre
N1 - Funding Information:
The authors thank Asif Chowdhury (Mount Sinai, New York), Saboor Hekmaty (Mount Sinai, New York) and Vernadette Simon (Mayo Clinic) for technical support, Wenjun Guo (Albert Einstein) for help with the mammary stem cell protocols, and Han Chen and Han Liang (MD Anderson, Houston, Texas), Steven Johnsen (Robert Bosch Center for Tumor Diseases, Stuttgart, Germany) and Lee Kraus (Southwestern Medical Center, Dallas, Texas) for help with access to their public datasets. This work was supported by the Mayo Clinic Center for Individualized Medicine, Center for Biomedical Discovery, the Department of Experimental Pathology and Lab Medicine, the New York Stem Cell Foundation Druckenmiller Fellowship (NYSCF-D-F41), Postdoctoral Fellowship in Breast Cancer Research Program, United States Department of Defense (BC100975) and the Mayo Clinic National Cancer Institute-designated Comprehensive Cancer Center Ovarian SPORE grant (Career Development Award P50 CA136393) to A.G.M.; NIH R01 CA154683 and NYSTEM IIRP C029573 to E.B.; NIH R35 CA253187 to F.J.C.; sequencing was supported in part through the Tisch Cancer Institute of the ISMMS Cancer Center Support Grant P30CA196521. Partial support for this work was provided by the grant CA236612 awarded to A.R. Illustration in Fig. was created with BioRender.com.
Funding Information:
The authors thank Asif Chowdhury (Mount Sinai, New York), Saboor Hekmaty (Mount Sinai, New York) and Vernadette Simon (Mayo Clinic) for technical support, Wenjun Guo (Albert Einstein) for help with the mammary stem cell protocols, and Han Chen and Han Liang (MD Anderson, Houston, Texas), Steven Johnsen (Robert Bosch Center for Tumor Diseases, Stuttgart, Germany) and Lee Kraus (Southwestern Medical Center, Dallas, Texas) for help with access to their public datasets. This work was supported by the Mayo Clinic Center for Individualized Medicine, Center for Biomedical Discovery, the Department of Experimental Pathology and Lab Medicine, the New York Stem Cell Foundation Druckenmiller Fellowship (NYSCF-D-F41), Postdoctoral Fellowship in Breast Cancer Research Program, United States Department of Defense (BC100975) and the Mayo Clinic National Cancer Institute-designated Comprehensive Cancer Center Ovarian SPORE grant (Career Development Award P50 CA136393) to A.G.M.; NIH R01 CA154683 and NYSTEM IIRP C029573 to E.B.; NIH R35 CA253187 to F.J.C.; sequencing was supported in part through the Tisch Cancer Institute of the ISMMS Cancer Center Support Grant P30CA196521. Partial support for this work was provided by the grant CA236612 awarded to A.R. Illustration in Fig. 1d was created with BioRender.com.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Considerable efforts have been made to characterize active enhancer elements, which can be annotated by accessible chromatin and H3 lysine 27 acetylation (H3K27ac). However, apart from poised enhancers that are observed in early stages of development and putative silencers, the functional significance of cis-regulatory elements lacking H3K27ac is poorly understood. Here we show that macroH2A histone variants mark a subset of enhancers in normal and cancer cells, which we coined ‘macro-Bound Enhancers’, that modulate enhancer activity. We find macroH2A variants localized at enhancer elements that are devoid of H3K27ac in a cell type-specific manner, indicating a role for macroH2A at inactive enhancers to maintain cell identity. In following, reactivation of macro-bound enhancers is associated with oncogenic programs in breast cancer and their repressive role is correlated with the activity of macroH2A2 as a negative regulator of BRD4 chromatin occupancy. Finally, through single cell epigenomic profiling of normal mammary stem cells derived from mice, we show that macroH2A deficiency facilitates increased activity of transcription factors associated with stem cell activity.
AB - Considerable efforts have been made to characterize active enhancer elements, which can be annotated by accessible chromatin and H3 lysine 27 acetylation (H3K27ac). However, apart from poised enhancers that are observed in early stages of development and putative silencers, the functional significance of cis-regulatory elements lacking H3K27ac is poorly understood. Here we show that macroH2A histone variants mark a subset of enhancers in normal and cancer cells, which we coined ‘macro-Bound Enhancers’, that modulate enhancer activity. We find macroH2A variants localized at enhancer elements that are devoid of H3K27ac in a cell type-specific manner, indicating a role for macroH2A at inactive enhancers to maintain cell identity. In following, reactivation of macro-bound enhancers is associated with oncogenic programs in breast cancer and their repressive role is correlated with the activity of macroH2A2 as a negative regulator of BRD4 chromatin occupancy. Finally, through single cell epigenomic profiling of normal mammary stem cells derived from mice, we show that macroH2A deficiency facilitates increased activity of transcription factors associated with stem cell activity.
UR - http://www.scopus.com/inward/record.url?scp=85148806199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148806199&partnerID=8YFLogxK
U2 - 10.1038/s42003-023-04571-1
DO - 10.1038/s42003-023-04571-1
M3 - Article
C2 - 36823213
AN - SCOPUS:85148806199
SN - 2399-3642
VL - 6
JO - Communications Biology
JF - Communications Biology
IS - 1
M1 - 215
ER -